Home/Filings/4/0001209191-05-063670
4//SEC Filing

LINNIK MATTHEW D 4

Accession 0001209191-05-063670

CIK 0000920465other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 6:56 PM ET

Size

8.0 KB

Accession

0001209191-05-063670

Insider Transaction Report

Form 4
Period: 2005-12-14
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
  • Award

    Common Stock

    2005-12-14+101,827108,324 total
Footnotes (1)
  • [F1]Restricted stock grant pursuant to that certain Retention Agreement, dated October 6, 2005.

Issuer

LA JOLLA PHARMACEUTICAL CO

CIK 0000920465

Entity typeother

Related Parties

1
  • filerCIK 0001237521

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 6:56 PM ET
Size
8.0 KB